Overview
John Bilezikian is an Internal Medicine provider in New York, New York. Dr. Bilezikian has been practicing medicine for over 53 years is highly rated in 21 conditions, according to our data. His top areas of expertise are Hyperparathyroidism, Hypoparathyroidism, Hypercalcemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
His clinical research consists of co-authoring 297 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
180 Fort Washington Ave, New York, NY 10032
Additional Areas of Focus
Dr. Bilezikian has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
CUIMC/Vivian & Seymour Milstein Family Heart Center
Mathew S. Maurer, MD - Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus. He is the Director of the Cardiac Amyloidosis Program. He has published over 300 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults. Dr. Maurer is highly rated in 21 conditions, according to our data. His top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR).
Icahn School Of Medicine At Mount Sinai
Mark Lebwohl is an Internal Medicine provider in New York, New York. Dr. Lebwohl is highly rated in 33 conditions, according to our data. His top areas of expertise are Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).
CUIMC/Herbert Irving Pavilion
Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is highly rated in 19 conditions, according to our data. Her top areas of expertise are Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Vulvectomy, and Salpingo-Oophorectomy.
Frequently Asked Questions about Dr. John Bilezikian
How do I make an appointment with Dr. John Bilezikian?
You can book an appointment with Dr. John Bilezikian by calling their office at 212-305-2663. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John Bilezikian a top-rated expert for Hyperparathyroidism?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John Bilezikian is classified as an Elite expert for Hyperparathyroidism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John Bilezikian specialize in?
While Dr. John Bilezikian is a Internal Medicine, they have specific expertise in Hyperparathyroidism, Hypoparathyroidism, and Parathyroidectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. John Bilezikian participate in research or clinical trials?
Yes. Dr. John Bilezikian has published 297 articles and abstracts on conditions like Hyperparathyroidism. You can view a list of Dr. John Bilezikian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John Bilezikian accept my insurance?
Dr. John Bilezikian accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-305-2663 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- HypercalcemiaDr. Bilezikian isElite. Learn about Hypercalcemia.
- HyperparathyroidismDr. Bilezikian isElite. Learn about Hyperparathyroidism.
- HypoparathyroidismDr. Bilezikian isElite. Learn about Hypoparathyroidism.
- Milk-Alkali SyndromeDr. Bilezikian isElite. Learn about Milk-Alkali Syndrome.
- OsteoporosisDr. Bilezikian isElite. Learn about Osteoporosis.
- ParathyroidectomyDr. Bilezikian isElite. Learn about Parathyroidectomy.
- Distinguished
- MalnutritionDr. Bilezikian isDistinguished. Learn about Malnutrition.
- Osteitis FibrosaDr. Bilezikian isDistinguished. Learn about Osteitis Fibrosa.
- Parathyroid HyperplasiaDr. Bilezikian isDistinguished. Learn about Parathyroid Hyperplasia.
- Advanced
- Familial Isolated HyperparathyroidismDr. Bilezikian isAdvanced. Learn about Familial Isolated Hyperparathyroidism.
- Fractured SpineDr. Bilezikian isAdvanced. Learn about Fractured Spine.
- Hormone Replacement Therapy (HRT)Dr. Bilezikian isAdvanced. Learn about Hormone Replacement Therapy (HRT).
- Hypophosphatasia (HPP)Dr. Bilezikian isAdvanced. Learn about Hypophosphatasia (HPP).
- HypophosphatemiaDr. Bilezikian isAdvanced. Learn about Hypophosphatemia.
- MenopauseDr. Bilezikian isAdvanced. Learn about Menopause.
- Experienced
- Autosomal Dominant HypocalcemiaDr. Bilezikian isExperienced. Learn about Autosomal Dominant Hypocalcemia.
- CalcinosisDr. Bilezikian isExperienced. Learn about Calcinosis.
- Congenital HypothyroidismDr. Bilezikian isExperienced. Learn about Congenital Hypothyroidism.
- Fibrous DysplasiaDr. Bilezikian isExperienced. Learn about Fibrous Dysplasia.
- Juvenile Primary OsteoporosisDr. Bilezikian isExperienced. Learn about Juvenile Primary Osteoporosis.
- Kienbock's DiseaseDr. Bilezikian isExperienced. Learn about Kienbock's Disease.

